Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8895588
Pyrazole compound
granted -
US 8884019
Benzimidazole compound crystal
granted -
US 8883788
Fused heterocyclic ring compound
granted -
US 8871273
Method for producing granules
granted -
US 8871766
Heterocyclic compounds
granted -
US 8865217
Oral preparation comprising pioglitazone
granted -
US 8865717
Heterocyclic compounds
granted -
US 8853215
Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
granted -
US 8846713
Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors
granted -
US 8835420
Azaindole derivatives
granted -
US 8829008
Organic compounds
granted -
US 8828429
Release-control composition
granted -
US 8822470
Substituted pyrido[2,3-b]pyrazines
granted -
US 8822699
Heterocyclic compound and use thereof
granted -
US 8821926
Tablet containing hardly soluble active ingredient
granted -
US 8815801
Controlled release composition and method of producing the same
granted -
US 8809542
Salts of benzimidazole compound and use thereof
granted -
US 8802695
Apoptosis signal-regulating kinase 1 inhibitors
granted -
US 8791107
N-substituted oxazinopteridines and oxazinopteridinones
granted -
US 8785460
Tricyclic compounds and use thereof
granted -
US 8785429
Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK
granted -
US 8784885
Controlled release preparation
granted -
US 8778944
Pyridazinone compounds
granted -
US 8778871
Metastin derivatives and use thereof
granted